FAPI imaging for right heart function in tricuspid valve leak
Part of Heart & circulation clinical trials.
This trial uses a special type of PET scan called FAPI to look at how well the right side of your heart is working when you have a leaky tricuspid valve. It may help doctors better understand and manage right heart strain caused by too much blood flow.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with tricuspid valve regurgitation (a leaky valve on the right side of your heart).
- You understand the purpose of the study and sign a consent form.
- You do not have significant narrowing of the coronary arteries (the arteries that supply blood to your heart muscle).
- You do not have an aortic aneurysm or related diseases (a bulge in the main artery from your heart).
- You do not have congenital heart disease (a heart problem you were born with).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses safe, non-invasive tests to study people with moderate or severe tricuspid regurgitation (leaky valve on the right side of the heart). It aims to better understand the condition, which may lead to improved care in the future.
This trial tests whether a special scan called FAPI-PET can predict heart problems in people with a chronic total occlusion (a completely blocked heart artery for at least 3 months). If you have this type of blockage and are planning to have a procedure to open it, this study may help guide your care.
This study is testing whether a special type of PET scan (called FAPI) can better see and understand fully blocked heart arteries (chronic total occlusions). If you're scheduled to have angioplasty to open such a blockage, this imaging might help guide the procedure.
This early (Phase 1) study compares two types of PET-CT scans to see how well they detect and measure lung scarring (pulmonary fibrosis). It may help doctors choose the best scan test for diagnosis in the future.
This trial uses a special PET scan tracer to see if it can help find and monitor diseases linked to a protein called FAP. It is for both cancer patients needing a biopsy and healthy volunteers.
This study uses a special type of heart scan (FAPI PET/CT) to better visualize and understand arrhythmogenic right ventricular cardiomyopathy (ARVC), a condition where the heart muscle weakens and causes irregular heartbeats. The scan may help doctors understand the disease better and improve patient care.
Hear when a new Tricuspid Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.